• Screened over 20,000 people for hepatitis B within San Francisco
• Launched the Clinician’s Honor Roll to educate Primary Care Physicians about hepatitis B and the importance of ensuring Asian and Pacific Islanders are screened and vaccinated for it. Over 90% of Clinicians within San Francisco have signed on to the honor roll, as of 2016, totaling more than 1,500 people.
• Developed and launched the San Francisco Business Initiative to educate
o Cold visits to small and large businesses throughout San Francisco’s high density pockets of Asian and Pacific Islander business establishments to educate employees about the significance of hepatitis B and the importance of testing and vaccination
o Directly reached out to over 500 businesses
o Directly educated over 1,500 employees
o Over 100 businesses officially signed on as Business Initiative partners – promising to pass on educational information to their employees
o 1 Business enacted policy change within their Human Relations Department to recommend hepatitis B screening and vaccination to all new hires
• Developed and hosted Viral Hepatitis educational summits (2 – 2015 & 2016)
o Focused on both hepatitis B and hepatitis C
o Over 100 people in attendance each year
o Audience comprised of nursing students, medical professionals, Department of Public Health workers, community leaders, and non-profit representatives
o Panels included speakers of national caliber –Dr. Ron Valdessari, Dr. Robert Gish, researcher from UCSF, American Liver Foundation executives, and State Health Department and elected official leaders
• Launched a new warm-line phone line navigator
o Phone line for hepatitis B questions, available in 2 languages, English & Chinese and in 3 dialects – Cantonese, Mandarin, Toisanese.
o Functions to help individuals answer hepatitis B related questions – explain their screening results, and encourage follow-up treatment for chronic infection
• Developed large-scale educational awareness events/projects
o Illumination of City Hall in the hepatitis B & C colors – in partnership with End Hep C SF, Hepatitis C Taskforce, and the Prevent Cancer Foundation
o SF Giants Heritage nights
o Japanese Consulate General Reception
o Ethnic media commercials/PSA – Crossings TV and Skylink TV
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close